Intrinsiqq
Avita Medical Inc. logo

Avita Medical Inc. Insider Trading

RCEL

⊜ Compare
Last 12 months

Insiders bought 235K on the open market and sold nothing.

Net open-market
+235K
9 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
2 / 0
executives and directors
Last open-market buy
Jun 2026
Jun 12, 2026

Get an email when RCEL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 12
    David D O'Toole
    CFO · bought 2,000 at $3.97
    8K
    1.3% of stake
  • Jun 9
    Joseph Fralin Woody
    Director · bought 5,200 at $4.00
    21K
    5.1% of stake
  • Jun 9
    Joseph Fralin Woody
    Director · bought 10,000 at avg $4.19
    42K
    11% of stake
  • Jun 3
    Joseph Fralin Woody
    Director · bought 10,000 at avg $4.10
    41K
    12% of stake
  • Jun 1 – 2
    Joseph Fralin Woody
    Director · bought 20,000 at avg $4.25
    85K
    New position
  • May 20
    David D O'Toole
    CFO · bought 2,000 at $4.26
    9K
    1.4% of stake
  • May 19
    David D O'Toole
    CFO · bought 2,000 at $4.24
    8K
    1.4% of stake
  • Mar 11
    David D O'Toole
    CFO · bought 1,800 at $4.78
    9K
    1.3% of stake
  • Feb 19
    David D O'Toole
    CFO · bought 3,000 at $4.15
    12K
    2.2% of stake
  • Aug 28, 2025
    Robert McNamara
    Director · bought 10,000 at $4.50
    45K
    13% of stake
  • Aug 26, 2025
    David D O'Toole
    CFO · bought 2,000 at $4.52
    9K
    6.7% of stake
  • Aug 19, 2025
    Robert McNamara
    Director · bought 10,000 at $5.00
    50K
    15% of stake
  • Aug 12, 2025
    David D O'Toole
    CFO · bought 2,000 at $4.81
    10K
    7.2% of stake
  • Mar 6, 2025
    Robert McNamara
    Director · bought 11,000 at $8.30
    91K
    24% of stake
  • Feb 20, 2025
    Robert McNamara
    Director · bought 10,000 at $10.09
    101K
    28% of stake
  • Feb 20, 2025
    David D O'Toole
    CFO · bought 1,000 at $9.90
    10K
    4.0% of stake
  • Feb 19, 2025
    David D O'Toole
    CFO · bought 1,000 at $10.25
    10K
    4.2% of stake
  • Dec 9, 2024
    Suzanne Crowe
    Director · bought 486 at $13.15
    6K
    1.3% of stake
  • Dec 5, 2024
    David D O'Toole
    CFO · bought 975 at avg $12.46
    12K
    4.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RCEL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RCEL

CompareIntrinsic value
PDEXPro-Dex Inc.
$63.44+5.31%86
TELATela Bio Inc.
$0.87+8.72%30
SGHTSight Sciences, Inc.
$9.68+2.76%33
IRMDIradimed Corp
$88.58+9.21%80
LUNGPulmonx Corporation
$2.83+4.04%30
CARLCarlsmed, Inc.
$16.09+11.74%44
CVRXCVRx, Inc.
$1.58+14.49%40
LNSRLensar Inc.
$5.84+4.85%40

Held by ETFs

RCEL is in 1 US ETF. The largest of them, with RCEL's weight in each:

Spot a number that looks wrong? Check it in RCEL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RCEL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.